Skip to content

Universe Pharmaceuticals INC (UPC) stock: revenue, earnings & dividend

Universe Pharmaceuticals INC (UPC, Nasdaq): revenue, earnings, dividend and balance sheet from official SEC filings.

Stock screener UPC ยท Nasdaq Pharma & Biotech CN

Key figures

Fiscal year
2025
Revenue
17.9 bn $
Revenue growth
-22.4 %
Revenue growth 5y (p.a.)
257.2 %
Net income
-3.67 bn $
Net margin
-20.6 %
Operating margin
-16.3 %
Earnings per share (diluted)
-8.06 $
Dividend per share
โ€“
Payout ratio
โ€“
Consecutive dividend years
โ€“
Consecutive dividend raises
โ€“
Dividend growth 5y (p.a.)
โ€“
Total assets
โ€“
Equity
โ€“
Equity ratio
โ€“
Return on equity
โ€“
Cash
โ€“
Operating cash flow
-5.05 bn $
Free cash flow
-5.32 bn $
Shares outstanding
โ€“

History

Revenue by fiscal year

2019 33.2 m $
2020 30.7 m $
2021 48 m $
2022 40.1 m $
2023 32.3 bn $
2024 23 bn $
2025 17.9 bn $

Net income by fiscal year

2020 7.56 m $
2021 11.3 m $
2022 -7.91 m $
2023 -6.58 bn $
2024 -8.73 bn $
2025 -3.67 bn $
YearRevenueNet incomeEPSDividend per shareOperating cash flow
202517.9 bn $-3.67 bn $-8.06 $โ€“-5.05 bn $
202423 bn $-8.73 bn $-626.96 $โ€“-9.51 bn $
202332.3 bn $-6.58 bn $-1,089.21 $โ€“1.12 bn $
202240.1 m $-7.91 m $-1,309.11 $โ€“-1.3 m $
202148 m $11.3 m $3.58 $โ€“-2.06 m $
202030.7 m $7.56 m $0.47 $โ€“6.12 m $
201933.2 m $โ€“โ€“โ€“13.2 m $

Data from XBRL filings at the SEC, processed automatically, no guarantee. Not investment advice. All filings at the SEC (EDGAR)